Tag: Health care industry
-
Jazz Pharmaceuticals to acquire Actio Biosciences for $820 million, expanding rare epilepsy portfolio
Jazz Pharmaceuticals will acquire Actio Biosciences, Inc., a deal that expands Jazz’s pipeline and presence in rare epilepsy treatments.
-
Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.
Lilly’s Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk’s Wegovy beyond the U.S. market.
-
Trump signs executive order calling for fewer childhood vaccines, falsely linking shots to autism
The order builds on the Trump administration’s efforts to reshape the childhood shot schedule under HHS Secretary RFK Jr., a longtime vaccine skeptic.
-
The power of genetic testing: new screening methods are catching rare diseases before symptoms start
Genetic testing is helping doctors identify rare diseases earlier, opening the door to treatment options before symptoms appear.
-
Why we like Boeing’s latest deal — plus, what to expect from this rebounding health stock
The Investing Club holds its “Morning Meeting” every weekday at 10:20 a.m. ET.
-
Cyclospora fears lead consumers to lose their appetite for salads
Traffic to salad chains has fallen as consumers avoid greens due to the ongoing cyclospora outbreaks across the U.S.
-
CAMP4 advances rare disease treatment for SYNGAP1 into human trials
CAMP4 is preparing a Phase 1/2 trial of an experimental SYNGAP1 therapy, marking a major milestone for patients with the rare disease.
-
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
-
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.
-
Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price
Instead of betting on which single pharmaceutical company wins a drug race, this company benefits as the industry grows by supplying the proprietary packaging.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
